FACULTY
Ajay Nehra, MD
Professor of Urology
Department of Urology
Mayo Clinic College of Medicine
Rochester, Minnesota

Richard Sadovsky, MD
Associate Professor of Family Medicine
State University of New York Health Science Center at Brooklyn
Brooklyn, New York

INTENDED AUDIENCE
This activity was developed for endocrinologists, urologists, primary care physicians, cardiologists, specialists, and healthcare providers interested in the management and treatment of hypogonadism and HIV.

STATEMENT OF NEED
The goal of this activity is to provide a more complete understanding of the epidemiology, diagnosis, and treatment of HIV as related to hypogonadism; describe the current understanding of HIV; and discuss how treating hypogonadism may improve both conditions and lead to improved overall health for some of these patients.

EDUCATIONAL OBJECTIVES
Patient outcomes could be measurably improved if physicians were better able to…

  1. Realize that men who are HIV positive are at increased risk for hypogonadism
  2. Recognize that increased clinical vigilance for comorbid HIV and hypogonadism may lead to improved healthcare outcomes
  3. Diagnose and evaluate symptoms of hypogonadism in HIV-infected men
  4. Identify patients with concomitant HIV and hypogonadism who may benefit from testosterone therapy

ACCREDITATION AND CERTIFICATION
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and CogniMed Inc. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no charge for this activity. Successful completion is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component. Statements of Credit will be provided by mail following activity participation and upon completion and electronic submission of the Posttest/Evaluation to CogniMed Inc. A link to the Posttest/Evaluation is provided upon completion of the activity. Please allow 4 to 6 weeks for the delivery of your statement.

DISCLOSURE STATEMENT
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationships with those supporting the activity or any others whose products or services are discussed. The faculty for this activity have disclosed that there may be discussion about the use of products for non–FDA-approved indications.

In accordance with the Accreditation Council for Continuing Medical Education standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

All staff at CogniMed Inc. have nothing to disclose.

Ajay Nehra, MD, has nothing to disclose.

Richard Sadovsky, MD, is a consultant for Eli Lilly and Company and Pfizer Inc. and serves on the speakers bureau of Pfizer Inc.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant provided by Endo Pharmaceuticals.

The estimated time to complete this activity is 1 hour.

This activity was originally released February 29, 2012, and is eligible for credit through February 28, 2013.

This piece was written by a medical writer and reviewed by faculty members. Faculty have final editorial control over the piece.


© 2012 CogniMed Inc. All rights reserved.            TU14137/ACHS 4972             February 2012